Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fontan Procedure | 11 | 2025 | 185 | 4.330 |
Why?
|
| Heart Defects, Congenital | 17 | 2025 | 1813 | 3.560 |
Why?
|
| Heart-Assist Devices | 7 | 2024 | 1045 | 2.170 |
Why?
|
| Heart Transplantation | 6 | 2024 | 858 | 1.760 |
Why?
|
| Heart Failure | 5 | 2024 | 2156 | 1.100 |
Why?
|
| Cardiac Catheterization | 2 | 2020 | 632 | 1.000 |
Why?
|
| Liver Diseases | 3 | 2023 | 366 | 0.800 |
Why?
|
| Echocardiography | 4 | 2025 | 1055 | 0.790 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2020 | 17 | 0.690 |
Why?
|
| Cardiac Rehabilitation | 1 | 2020 | 24 | 0.680 |
Why?
|
| Biological Products | 1 | 2021 | 116 | 0.680 |
Why?
|
| Pulmonary Artery | 2 | 2020 | 440 | 0.650 |
Why?
|
| Aorta | 2 | 2020 | 549 | 0.650 |
Why?
|
| Heterotaxy Syndrome | 1 | 2019 | 61 | 0.640 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2020 | 172 | 0.630 |
Why?
|
| Down Syndrome | 2 | 2020 | 195 | 0.630 |
Why?
|
| Central Venous Pressure | 1 | 2018 | 25 | 0.620 |
Why?
|
| Exercise Therapy | 1 | 2020 | 153 | 0.610 |
Why?
|
| Tricuspid Atresia | 1 | 2018 | 14 | 0.600 |
Why?
|
| Specialization | 1 | 2019 | 76 | 0.600 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 269 | 0.600 |
Why?
|
| Arterial Switch Operation | 1 | 2018 | 22 | 0.590 |
Why?
|
| Shock | 1 | 2019 | 90 | 0.580 |
Why?
|
| Turner Syndrome | 1 | 2018 | 47 | 0.570 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 151 | 0.560 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2021 | 1103 | 0.550 |
Why?
|
| Survivors | 1 | 2019 | 344 | 0.550 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2020 | 252 | 0.550 |
Why?
|
| Creatinine | 1 | 2018 | 382 | 0.530 |
Why?
|
| Disease Management | 1 | 2020 | 522 | 0.530 |
Why?
|
| Palliative Care | 1 | 2020 | 430 | 0.530 |
Why?
|
| Renal Insufficiency | 1 | 2018 | 234 | 0.510 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 484 | 0.490 |
Why?
|
| Chromosome Aberrations | 1 | 2018 | 621 | 0.470 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 508 | 0.450 |
Why?
|
| Retrospective Studies | 13 | 2025 | 16195 | 0.440 |
Why?
|
| Cardiology | 1 | 2019 | 476 | 0.430 |
Why?
|
| Postoperative Complications | 3 | 2023 | 3045 | 0.430 |
Why?
|
| Tissue Engineering | 2 | 2011 | 176 | 0.410 |
Why?
|
| Adult | 14 | 2024 | 29303 | 0.380 |
Why?
|
| Polyurethanes | 1 | 2011 | 18 | 0.380 |
Why?
|
| Polymers | 1 | 2011 | 107 | 0.350 |
Why?
|
| Liver Transplantation | 3 | 2023 | 1034 | 0.350 |
Why?
|
| Humans | 27 | 2025 | 124083 | 0.340 |
Why?
|
| Pyrroles | 1 | 2011 | 178 | 0.330 |
Why?
|
| Young Adult | 6 | 2024 | 8939 | 0.310 |
Why?
|
| Heart Ventricles | 3 | 2025 | 768 | 0.310 |
Why?
|
| Nanoparticles | 1 | 2011 | 230 | 0.310 |
Why?
|
| Internship and Residency | 1 | 2019 | 1167 | 0.310 |
Why?
|
| Postoperative Period | 2 | 2020 | 333 | 0.300 |
Why?
|
| Transposition of Great Vessels | 2 | 2020 | 131 | 0.290 |
Why?
|
| Treatment Outcome | 5 | 2024 | 12240 | 0.270 |
Why?
|
| Adolescent | 9 | 2025 | 19269 | 0.270 |
Why?
|
| Hospitalization | 3 | 2024 | 1751 | 0.250 |
Why?
|
| Atrial Function | 1 | 2025 | 14 | 0.250 |
Why?
|
| Male | 12 | 2025 | 60804 | 0.230 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2023 | 30 | 0.220 |
Why?
|
| Endocarditis | 1 | 2024 | 105 | 0.210 |
Why?
|
| Heart Atria | 1 | 2025 | 317 | 0.200 |
Why?
|
| Time Factors | 2 | 2024 | 6256 | 0.190 |
Why?
|
| Child | 8 | 2025 | 24417 | 0.190 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 268 | 0.190 |
Why?
|
| Hemodynamics | 2 | 2023 | 847 | 0.180 |
Why?
|
| Cyanosis | 1 | 2021 | 41 | 0.180 |
Why?
|
| Models, Cardiovascular | 1 | 2021 | 183 | 0.180 |
Why?
|
| Treatment Failure | 1 | 2021 | 339 | 0.180 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 2020 | 10 | 0.180 |
Why?
|
| Middle Aged | 5 | 2024 | 26316 | 0.180 |
Why?
|
| Hospital Mortality | 3 | 2024 | 1016 | 0.170 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2021 | 63 | 0.170 |
Why?
|
| Biocompatible Materials | 2 | 2011 | 123 | 0.170 |
Why?
|
| Female | 9 | 2025 | 66156 | 0.160 |
Why?
|
| Hydrodynamics | 1 | 2019 | 18 | 0.160 |
Why?
|
| Iatrogenic Disease | 1 | 2020 | 132 | 0.160 |
Why?
|
| Patients | 1 | 2020 | 121 | 0.160 |
Why?
|
| Swine | 1 | 2021 | 1170 | 0.150 |
Why?
|
| Comorbidity | 2 | 2021 | 1505 | 0.150 |
Why?
|
| Endothelial Cells | 1 | 2021 | 527 | 0.150 |
Why?
|
| Heart Valves | 1 | 2018 | 51 | 0.150 |
Why?
|
| Health Status | 1 | 2019 | 376 | 0.140 |
Why?
|
| Cause of Death | 1 | 2019 | 466 | 0.140 |
Why?
|
| Risk Factors | 3 | 2021 | 10107 | 0.130 |
Why?
|
| Hypertension, Pulmonary | 1 | 2021 | 434 | 0.130 |
Why?
|
| Communication | 1 | 2020 | 516 | 0.130 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 366 | 0.130 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 5086 | 0.120 |
Why?
|
| Child, Preschool | 3 | 2025 | 14021 | 0.120 |
Why?
|
| Materials Testing | 2 | 2011 | 73 | 0.110 |
Why?
|
| Texas | 2 | 2020 | 3586 | 0.110 |
Why?
|
| Stents | 1 | 2020 | 879 | 0.110 |
Why?
|
| Curriculum | 1 | 2019 | 722 | 0.110 |
Why?
|
| Disease Progression | 1 | 2019 | 2037 | 0.110 |
Why?
|
| Age Factors | 1 | 2019 | 2815 | 0.100 |
Why?
|
| Electrochemical Techniques | 1 | 2011 | 6 | 0.090 |
Why?
|
| Myoblasts | 1 | 2011 | 30 | 0.090 |
Why?
|
| Electric Conductivity | 1 | 2011 | 89 | 0.090 |
Why?
|
| Ear Cartilage | 1 | 2010 | 2 | 0.090 |
Why?
|
| Cross-Sectional Studies | 3 | 2025 | 3406 | 0.090 |
Why?
|
| Incidence | 1 | 2018 | 3074 | 0.090 |
Why?
|
| United States | 3 | 2024 | 10739 | 0.090 |
Why?
|
| Prostheses and Implants | 1 | 2010 | 150 | 0.080 |
Why?
|
| Hair | 1 | 2009 | 22 | 0.080 |
Why?
|
| Keratins | 1 | 2009 | 55 | 0.080 |
Why?
|
| Hemostatics | 1 | 2009 | 58 | 0.080 |
Why?
|
| Animals | 5 | 2021 | 34094 | 0.080 |
Why?
|
| Infant | 2 | 2020 | 12439 | 0.070 |
Why?
|
| Cell Line | 1 | 2011 | 2779 | 0.060 |
Why?
|
| Infant, Newborn | 1 | 2018 | 8158 | 0.060 |
Why?
|
| Diastole | 1 | 2025 | 170 | 0.060 |
Why?
|
| Liver | 2 | 2023 | 1757 | 0.050 |
Why?
|
| Cardiac Output | 1 | 2023 | 170 | 0.050 |
Why?
|
| Morbidity | 1 | 2023 | 243 | 0.050 |
Why?
|
| Diuretics | 1 | 2023 | 159 | 0.050 |
Why?
|
| Patient Acuity | 1 | 2021 | 64 | 0.050 |
Why?
|
| Causality | 1 | 2021 | 83 | 0.050 |
Why?
|
| Symptom Assessment | 1 | 2021 | 100 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2021 | 73 | 0.040 |
Why?
|
| Aged | 3 | 2024 | 19349 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2021 | 121 | 0.040 |
Why?
|
| Mortality | 1 | 2021 | 229 | 0.040 |
Why?
|
| Survival Rate | 1 | 2024 | 2016 | 0.040 |
Why?
|
| Rabbits | 2 | 2010 | 710 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 4344 | 0.040 |
Why?
|
| Ethylene Dibromide | 1 | 1976 | 1 | 0.030 |
Why?
|
| Hydrocarbons, Brominated | 1 | 1976 | 7 | 0.030 |
Why?
|
| Global Health | 1 | 2021 | 554 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 1344 | 0.030 |
Why?
|
| Mice | 1 | 2011 | 17716 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2023 | 4727 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 6084 | 0.030 |
Why?
|
| Chondrocytes | 1 | 2010 | 48 | 0.020 |
Why?
|
| Thrombin | 1 | 2010 | 59 | 0.020 |
Why?
|
| Hydrogels | 1 | 2010 | 80 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2010 | 152 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 314 | 0.020 |
Why?
|
| Heart Rate | 1 | 2009 | 590 | 0.020 |
Why?
|
| Amino Acids | 1 | 2009 | 663 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2009 | 967 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2009 | 1329 | 0.010 |
Why?
|
| Thiamphenicol | 1 | 1981 | 1 | 0.010 |
Why?
|
| Anemia, Aplastic | 1 | 1981 | 60 | 0.010 |
Why?
|
| Fats | 1 | 1976 | 13 | 0.010 |
Why?
|
| Poisoning | 1 | 1976 | 16 | 0.010 |
Why?
|
| Chickens | 1 | 1976 | 638 | 0.010 |
Why?
|
| Species Specificity | 1 | 1976 | 550 | 0.010 |
Why?
|
| Rats | 1 | 1976 | 3685 | 0.010 |
Why?
|
| Chloramphenicol | 1 | 1981 | 29 | 0.000 |
Why?
|
| Erythropoiesis | 1 | 1981 | 40 | 0.000 |
Why?
|
| Acute Disease | 1 | 1981 | 1096 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1981 | 1694 | 0.000 |
Why?
|